Quantcast

Latest Medicines for Malaria Venture Stories

2014-09-15 20:22:06

Seven New Grant Investments for $15.3 Million to Tackle Malaria, Chagas Disease and Dengue, which is Dramatically on the Rise TOKYO, Sept. 15, 2014 /PRNewswire-USNewswire/ -- The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, today announced seven grant investments totaling US$15.3 million to speed the development of promising drugs and vaccines to battle...

2013-05-30 23:24:47

Pro-Bono Work Using Freeslate CM3 Reaction Screening System Achieved Near 100 Percent Chiral Resolution for Important Drug Intermediate SUNNYVALE, Calif (PRWEB) May 30, 2013 Freeslate, Inc., the leading provider of high throughput research solutions, today announced outcomes following a pro-bono study with researchers from Rutgers University in New Jersey working with Medicines for Malaria Venture (MMV, http://www.mmv.org) to discover new antimalarial agents. Using Freeslate´s CM3...

2013-03-21 16:13:24

Drug may be major advance as malaria has developed resistance to existing treatments Scientists at Oregon Health & Science University and the Portland VA Medical Center have developed a drug that may represent one of the world's best hopes for treating and preventing malaria – a disease that kills more than one million people each year. The scientists have described the drug, and its effectiveness against mice infected with malaria, in the March 20 issue of Science...

2012-08-23 00:55:46

Medicines for Malaria Venture has developed a framework to evaluate the risk of resistance for the antimalarial compounds in its portfolio. A paper based on this work: A framework for assessing the risk of resistance for antimalarials in development has been published in the Malaria Journal today. Resistance defines the longevity of every anti-infective drug, so it is important when developing new medicines for malaria, to check how easily promising antimalarial compounds will select for...

2011-11-18 03:28:21

Data publicly available for global discovery The discovery of a new class of dual-acting antimalarial compounds - the imidazolopiperazines (IZPs) — was published in the journal Science online, at the Science Express website today1. The findings report on compounds that target both liver and blood infections, attacking the Plasmodium parasite at both stages in its reproduction cycle. The findings describe how scientists developed a novel assay to determine liver stage activity of...

4b27f6405dffbc7030da76d4ed46d05d1
2011-01-13 08:00:00

A drug-resistant strain of malaria could spread from southeast Asia to Africa in as little as three months, which puts millions of children at risk, according to a warning from a leading expert Wednesday. Nicholas White, professor of tropical medicine at Mahidol University in Bangkok, said its time to bring a war against malaria before it is too late. The new strain is resistant to the drug artemisinin that was first used along the Thai-Cambodian border in 2007. The new longer-to-treat form...

2010-01-20 08:09:00

PHILADELPHIA and LONDON, Jan. 20 /PRNewswire-FirstCall/ -- 'Open Lab' established with $8m seed funding for new research 13,500 malaria compounds to be made freely available New collaborations to share intellectual property for neglected tropical diseases Pledge to create sustainable pricing model for world's most advanced malaria candidate vaccine GSK African Malaria Partnership awards four new grants worth $2.5m Andrew Witty, Chief Executive of GlaxoSmithKline (NYSE: GSK), today...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.